Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Blood Cancer Journal
|
June 29, 2026
Circulating CD20-positive extracellular vesicles impair rituximab efficacy and predict outcomes in diffuse large B-cell lymphoma
Bon Park, Kyung Ju Ryu, Min Kyu Choi, et al.
Cancers
|
November 26, 2022
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
Seok Jin Kim, Kyung Ju Ryu, Bon Park, et al.
Scientific Reports
|
February 25, 2025
MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma
Kyung Ju Ryu, Haein Ji, Bon Park, et al.
Annals of Laboratory Medicine
|
September 30, 2024
Feasibility of Circulating Tumor DNA Detection in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement in Large B-Cell Lymphoma
Seok Jin Kim, Jin Ju Kim, Mi Ri Park, et al.
Experimental Cell Research
|
September 11, 2024
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
Bon Park, Myung Eun Choi, Kyung Ju Ryu, et al.
Journal of Cancer
|
April 4, 2022
Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
Yeong Hak Bang, Joon Ho Shim, Kyung Ju Ryu, et al.
Cancer Research and Treatment
|
March 3, 2022
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Seok Jin Kim, Yeon Jeong Kim, Sang Eun Yoon, et al.
Research in Veterinary Science
|
November 14, 2012
Aberrant gene expression patterns in extraembryonic tissue from cloned porcine embryos
Mi-Ryung Park, Gi-Sun Im, Sung Woo Kim, et al.
Blood Advances
|
December 9, 2025
Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphoma
Sang Eun Yoon, Woorim Kang, Junhun Cho, et al.
Blood
|
March 12, 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell Lymphoma
Seok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Blood Cancer Journal
|
June 29, 2026
Circulating CD20-positive extracellular vesicles impair rituximab efficacy and predict outcomes in diffuse large B-cell lymphoma
Bon Park, Kyung Ju Ryu, Min Kyu Choi, et al.
Cancers
|
November 26, 2022
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
Seok Jin Kim, Kyung Ju Ryu, Bon Park, et al.
Scientific Reports
|
February 25, 2025
MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma
Kyung Ju Ryu, Haein Ji, Bon Park, et al.
Annals of Laboratory Medicine
|
September 30, 2024
Feasibility of Circulating Tumor DNA Detection in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement in Large B-Cell Lymphoma
Seok Jin Kim, Jin Ju Kim, Mi Ri Park, et al.
Experimental Cell Research
|
September 11, 2024
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
Bon Park, Myung Eun Choi, Kyung Ju Ryu, et al.
Journal of Cancer
|
April 4, 2022
Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
Yeong Hak Bang, Joon Ho Shim, Kyung Ju Ryu, et al.
Cancer Research and Treatment
|
March 3, 2022
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Seok Jin Kim, Yeon Jeong Kim, Sang Eun Yoon, et al.
Research in Veterinary Science
|
November 14, 2012
Aberrant gene expression patterns in extraembryonic tissue from cloned porcine embryos
Mi-Ryung Park, Gi-Sun Im, Sung Woo Kim, et al.
Blood Advances
|
December 9, 2025
Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphoma
Sang Eun Yoon, Woorim Kang, Junhun Cho, et al.
Blood
|
March 12, 2025
Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed/Refractory NK/T-Cell Lymphoma
Seok Jin Kim, Jing Quan Lim, Sang Eun Yoon, et al.
Page
of 1